Siddiqui Sarah
Known title: EVP, CHROCIK: 0001966801
Associated companies
Transaction History
| NDSN | ▼ Sell | Tax Withholding | 30 | $9K | 2/27/2026 | View on chart |
| NDSN | ▼ Sell | Tax Withholding | 117 | $29K | 1/5/2026 | View on chart |
| NDSN | ▲ Buy | Grant | 408 | $100K | 1/5/2026 | View on chart |
| NDSN | ▲ Buy | Grant | 1,023 | $246K | 12/20/2025 | View on chart |
| NDSN | ▼ Sell | Tax Withholding | 95 | $23K | 12/19/2025 | View on chart |
| NDSN | ▼ Sell | Tax Withholding | 106 | $25K | 12/1/2025 | View on chart |
| NDSN | ▼ Sell | Tax Withholding | 31 | $7K | 2/28/2025 | View on chart |
| NDSN | ▼ Sell | Tax Withholding | 600 | $124K | 1/6/2025 | View on chart |
| NDSN | ▲ Buy | Grant | 2,043 | $423K | 1/6/2025 | View on chart |
| NDSN | ▲ Buy | Grant | 641 | $134K | 12/20/2024 | View on chart |
| NDSN | ▲ Buy | Grant | 1,001 | $210K | 12/20/2024 | View on chart |
| NDSN | ▼ Sell | Tax Withholding | 70 | $18K | 11/29/2024 | View on chart |
| NDSN | ▼ Sell | Tax Withholding | 36 | $10K | 3/1/2024 | View on chart |
| NDSN | ▲ Buy | Grant | 716 | $171K | 12/1/2023 | View on chart |
| NDSN | ▲ Buy | Grant | 311 | $68K | 3/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Nordson Packaging Recovery Cited Amid Valuation Concerns
Recent commentary highlights a genuine recovery in Nordson's packaging segment, though analysts note the stock price reflects this optimism. The company trades at a trailing P/E of 32.8, which some view as a premium relative to its current valuation. With the stock near its 52-week high, the market is closely watching whether operational improvements can justify the current price point.
Nordson Packaging Recovery Cited Amid Valuation Concerns. Recent commentary highlights a genuine recovery in Nordson's packaging segment, though analysts note the stock price reflects this optimism. The company trades at a trailing P/E of 32.8, which some view as a premium relative to its current valuation. With the stock near its 52-week high, the market is closely watching whether operational improvements can justify the current price point.